Vimarsana
Biggest News Aggregation in the World

Eric Lawless News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Eric Lawless. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Eric Lawless Today - Breaking & Trending Today

Kildare Nationalist — Kildare medical tourism firm eyes partnerships with Irish clinics - Vimarsana News

Kildare Nationalist — Kildare medical tourism firm eyes partnerships with Irish clinics

Velacor, a medical tourism platform established by a Kildare entrepreneur, has announced a planned partnership with Irish clinics.

Kildare Nationalist — Local firm aims to connect people seeking overseas procedures with trusted clinics worldwide - Vimarsana News

Kildare Nationalist — Local firm aims to connect people seeking overseas procedures with trusted clinics worldwide

A Kildare-based entrepreneur is behind a tech startup in the medical tourism industry.

Odyssey Interactive Raises $19M in Series A Funding - Vimarsana News

Odyssey Interactive Raises $19M in Series A Funding

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Odyssey Interactive secures $19m in Series A funding round - Vimarsana News

Odyssey Interactive secures $19m in Series A funding round

Independent games studio Odyssey Interactive has raised $19 million in a Series A funding round. The round was led by M…

Cambridge Biotech Startup Relocates to Woburn - Banker & Tradesman - Vimarsana News

Cambridge Biotech Startup Relocates to Woburn - Banker & Tradesman

Photo courtesy of Cummings Properties A Cambridge biotech is moving from a shared lab space in that city to a dedicated Woburn office following the signing of a lease. Rgenta Theraputics will take 5,400 square feet in Cummings Properties’ TradeCenter 128, moving on from rented space in the LabCentral incubator space. Rgenta is developing oral treatments for historically incurable diseases. Its team of small-molecule drug developers is currently focused on pioneering new medicines for cancers and neurological disorders. The venture capital-backed firm announced its receipt of $20 million in ...